208 related articles for article (PubMed ID: 7826677)
1. DNA recognition by lexitropsins, minor groove binding agents.
Lown JW
J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
[TBL] [Abstract][Full Text] [Related]
2. Ligands recognizing the minor groove of DNA: development and applications.
Wemmer DE
Biopolymers; 1999-2000; 52(4):197-211. PubMed ID: 11295751
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance.
Rao KE; Shea RG; Yadagiri B; Lown JW
Anticancer Drug Des; 1990 Feb; 5(1):3-20. PubMed ID: 2156516
[TBL] [Abstract][Full Text] [Related]
4. Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes.
Lown JW
Anticancer Drug Des; 1988 Jun; 3(1):25-40. PubMed ID: 2838035
[TBL] [Abstract][Full Text] [Related]
5. Carbocyclic analogues of netropsin and distamycin: DNA-binding properties and inhibition of DNA topoisomerases.
Bartulewicz D; Bielawski K; Bielawska A
Arch Pharm (Weinheim); 2002 Nov; 335(9):422-6. PubMed ID: 12447915
[TBL] [Abstract][Full Text] [Related]
6. Progress in the design of DNA sequence-specific lexitropsins.
Walker WL; Kopka ML; Goodsell DS
Biopolymers; 1997; 44(4):323-34. PubMed ID: 9782774
[TBL] [Abstract][Full Text] [Related]
7. Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition.
Nikolaev VA; Grokhovsky SL; Surovaya AN; Leinsoo TA; Sidorova NYu ; Zasedatelev AS; Zhuze AL; Strahan GA; Shafer RH; Gursky GV
J Biomol Struct Dyn; 1996 Aug; 14(1):31-47. PubMed ID: 8877560
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition between oligopeptides and nucleic acids. Specificity of binding of a monocationic bis-furan lexitropsin to DNA deduced from footprinting and 1H NMR studies.
Lee M; Krowicki K; Shea RG; Lown JW; Pon RT
J Mol Recognit; 1989 Sep; 2(2):84-93. PubMed ID: 2561528
[TBL] [Abstract][Full Text] [Related]
9. Carbocyclic analogues of lexitropsin--DNA affinity and endonuclease inhibition.
Pućkowska A; Drozdowska D; Midura-Nowaczek K
Acta Pol Pharm; 2007; 64(2):115-9. PubMed ID: 17665860
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
[TBL] [Abstract][Full Text] [Related]
11. Non-covalent ligand/DNA interactions: minor groove binding agents.
Nelson SM; Ferguson LR; Denny WA
Mutat Res; 2007 Oct; 623(1-2):24-40. PubMed ID: 17507044
[TBL] [Abstract][Full Text] [Related]
12. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
Bell A; Kittler L; Löber G; Zimmer C
J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in sequence selective minor groove DNA effectors.
Reddy BS; Sharma SK; Lown JW
Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
[TBL] [Abstract][Full Text] [Related]
14. The binding of prototype lexitropsins to the minor groove of DNA: quantum chemical studies.
Mazurek P; Feng W; Shukla K; Sapse AM; Lown JW
J Biomol Struct Dyn; 1991 Oct; 9(2):299-313. PubMed ID: 1660279
[TBL] [Abstract][Full Text] [Related]
15. Energetic diversity of DNA minor-groove recognition by small molecules displayed through some model ligand-DNA systems.
Lah J; Vesnaver G
J Mol Biol; 2004 Sep; 342(1):73-89. PubMed ID: 15313608
[TBL] [Abstract][Full Text] [Related]
16. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
17. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency.
Guo D; Gupta R; Lown JW
Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044
[TBL] [Abstract][Full Text] [Related]
18. DNA recognition by intercalators and hybrid molecules.
Waring MJ; Bailly C
J Mol Recognit; 1994 Jun; 7(2):109-22. PubMed ID: 7826671
[TBL] [Abstract][Full Text] [Related]
19. Sequence recognition of DNA by lexitropsins.
Goodsell DS
Curr Med Chem; 2001 Apr; 8(5):509-16. PubMed ID: 11281838
[TBL] [Abstract][Full Text] [Related]
20. [Specific protection of DNA by distamycin A, netropsin and bis-netropsins against the action of DNAse I].
Skamrov AV; Rybalkin IN; Bibilashvili RSh; Gottikh BP; Grokhovskiĭ SL
Mol Biol (Mosk); 1985; 19(1):177-95. PubMed ID: 2984546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
